Kilder: Brosjyre om ALL

Her finner du fullstendig kildeliste og henvisninger benyttet i brosjyre om ALL.

Publisert 03. mars 2020

Kilder:

https://nhi.no/sykdommer/barn/kreftsykdommer/akutt-lymfoblastisk-leukemi/?page=all

https://kreftlex.no/Leukemi/BAKGRUNN/Arsak?CancerType=Leukemi

https://helsenorge.no/sykdom/kreft/leukemi-blodkreft

https://www.helsedirektoratet.no/retningslinjer/maligne-blodsykdommer-handlingsprogram/Maligne%20blodsykdommer%20%E2%80%93%20Nasjonalt%20handlingsprogram%20med%20retningslinjer%20for%20diagnostikk,%20behandling%20og%20oppf%C3%B8lging.pdf/_/attachment/inline/e7b48126-ca7f-4910-81d1-9b5a0a52faf2:74c6e155844c44c1fa1bb2198a89650a0b4945a9/Maligne%20blodsykdommer%20%E2%80%93%20Nasjonalt%20handlingsprogram%20med%20retningslinjer%20for%20diagnostikk,%20behandling%20og%20oppf%C3%B8lging.pdf

https://www.cancer.org/cancer/acute-lymphocytic-leukemia/about/new-research.html

Evensen, Stein A.. (2016, 13. oktober). Philadelphia-kromosom. I Store medisinske leksikon. Hentet 25. februar 2020 fra https://sml.snl.no/Philadelphia-kromosom

Referanser:

Referanser (NHI.no):

 

  1. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av maligne blodsykdommer. IS-2746. Oslo, sept. 2018. www.helsedirektoratet.no
  2. Cortelazzo S, Ponzoni M, Ferreri AJM, Hoelzer D. Lymphoblastic lymphoma. Crit Rev Oncol Hematol 2011; 79: 330-43. PMID: 21273093 PubMed
  3. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127: 2391-405. pmid:27069254 PubMed
  4. Danckert B, Ferlay J, Engholm G et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.2 (26.03.2019). Hentet 30.04.19 ancr.nu
  5. Cancer in Norway 2015. Oslo: Kreftregisteret, 2016. www.kreftregisteret.no
  6. Kolmannskog S, Flægstad T, Helgestad J, Hellebostad M, Zeller B, Glomstein A. Akutt lymfatisk leukemi hos barn i Norge 1992-2000. Tidsskr Nor Lægeforen 2007; 127: 1493-5. PMID: 17551551 PubMed
  7. Pui CH, Robison LL, Look AT.. Acute lymphoblastic leukaemia. Lancet 2008; 371: 1030-43. pmid:18358930 PubMed
  8. Freedman AS, Aster JC. Clinical manifestations, pathologic features, and diagnosis of precursor B cell acute lymphoblastic leukemia/lymphoma. Oct. 2016. www.uptodate.com
  9. Pui C-H, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166-78. PMID: 16407512 PubMed
  10. Maury S, Chevret 1, Thomas X et al. Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia. N Engl J Med 2016; 375: 1144-53. pmid: 27626518 PubMed
  11. Fløisand Y1, Brinch L, Dybedal I et al. Allogen stamcelletransplantasjon hos voksne med akutt lymfoblastisk leukemi. Tidsskr Nor Laegeforen 2008; 128: 2563-6. pmid:19023351 PubMed
  12. Bassan R, Hoelzer D. Modern therapy of acute lymphoblastic leukemia. J Clin Oncol 2011; 29: 532-43. PMID: 21220592 PubMed
  13. Rowe JM. Prognostic factors in adult acute lymphoblastic leukaemia. Br J Haematol 2010;150(4):389-405. PMID: 20573154 PubMed
  14. Marks DI. Treating the «older» adult with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2010;American Society of Hematology. Education Program. 2010:13-20. PMID: 21239765 PubMed
  15. Ram R, Gafter-Gvili A, Vidal L, et al. Management of adult patients with acute lymphoblastic leukemia in first complete remission: Systematic review and meta-analysis. Cancer 2010; 116: 3447-57. PMID: 20564092 PubMed
  16. Lee HJ, Thompson JE, Wang ES, Wetzler M. Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer 2011;117(8):1583-94. PMID: 21472706 PubMed
  17. Goldstone AH, Rowe JM. Transplantation in adult ALL. Hematology Am Soc Hematol Educ Program 2009;593-601. PMID: 20008244 PubMed
  18. Jabbour E, O’Brien S, Ravandi F, et al. Monoclonal antibodies in acute lymphoblastic leukemia. Blood. 2015 ;125:4010-6. PMID: 25999456 PubMed
  19. Kantarjian HM, DeAngelo DJ, Stelljes M et al. Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia. N Engl J Med 2016; 375: 740-53. pmid:27292104 PubMed
  20. Maude SL, Laetsch TW, Buechner J et al. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. N Engl J Med 2018; 378: 439-48. pmid:29385370 PubMed
  21. Seneffekter etter kreftbehandling. Faglige råd. Oslo: Helsedirektoratet; 2017. IS-2551 oslo-universitetssykehus.no
  22. Tangen JM, Fløisand Y, Haukås E, Næss IA, Skjelbakken T, Stapnes C, et al. Overlevelse hos voksne med akutt lymfoblastisk leukemi. Tidsskr Nor Lægeforen 2010; 130: 1710-3. DOI: 10.4045/tidsskr.09.1293 DOI
  23. Tjønnfjord GE, Gedde-Dahl T, Heldal D, Brinch L. Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival. Leukemia 2007; 21: 2203-4. PMID: 17525727 PubMed
  24. Hijiya N, Hudson MM, Lensing S, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 2007; 297: 1207-15. PMID: 17374815 PubMed
  25. Pui C-H, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535-48. PMID: 15071128 PubMed
  26. Martell MP, Atenafu EG, Minden MD et al. Treatment of elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocol. Br J Haematol 2013; 163: 458-64. pmid:24033272 PubMed